Sunday, May 26, 2019

Glenmark Pharma gets USFDA nod for antiplatelet drug

Glenmark Pharmaceuticals Inc, USA has been granted final approval by the United States Food & Drug Administration (USFDA) for Aspirin and extended-release Dipyridamole capsules in the strength of 25 mg/200 mg, the company said in a BSE filing.

from Moneycontrol http://bit.ly/2McVf7L

No comments:

Post a Comment

  Finding symbol of isotops by proton and neutron